Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
42,317,827
-
Share change
-
+1,999,357
-
Total reported value
-
$4,013,539,579
-
Put/Call ratio
-
58%
-
Price per share
-
$94.83
-
Number of holders
-
288
-
Value change
-
+$196,965,676
-
Number of buys
-
135
-
Number of sells
-
156
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2020
As of 31 Mar 2020,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
288 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,317,827 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Consonance Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., DIMENSIONAL FUND ADVISORS LP, and Palo Alto Investors LP.
This page lists
290
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.